Herbert Fritsche

No ORCID on file · 2 papers in corpus

diagnostic-accuracy 2023

Validation of a deep neural network-based algorithm supporting clinical management of adnexal mass

Frontiers in medicine ·doi:10.3389/fmed.2023.1102437

BACKGROUND: Conservative management of adnexal mass is warranted when there is imaging-based and clinical evidence of benign characteristics. Malignancy risk is, however, a concern due to the mortality rate of ovarian cancer. Malignancy occ…

other 2007

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

Gynecologic Oncology ·doi:10.1016/j.ygyno.2007.04.022

OBJECTIVES: Early detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect early stage disease, but few urine markers have been studied. Mesothelin has been detected…